US EditionPublished • loading... • Updated
Unscheduled Care Data Flags Patients at High Risk of Liver Disease
Summary by European Medical Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Gilead Sciences has participated in the 51st Congress of the Spanish Association for the Study of the Liver (AEEH), held in Madrid, where it has reaffirmed its support for patients, specialists and research in hepatology under the motto ‘Account me, we are and we will be, together, in the face of liver diseases’. During the meeting, the company focused on the importance of diagnosis and early treatment in Delta hepatitis (VHD), the challenges in…
·Madrid, Spain
Read Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
